<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".02" citation="COMAR 10.67.12.02" title_num="10" subtitle_num="67" chapter_num="12" heading="Corrective Managed Care Plan.">
  <paragraph num="A.">
    <text>An MCO’s corrective managed care plan:</text>
    <paragraph num="(1)">
      <text>Shall cover enrollee abuse of medical assistance pharmacy benefits; and</text>
    </paragraph>
    <paragraph num="(2)">
      <text>May cover enrollee abuse of nonpharmacy medical assistance benefits.</text>
    </paragraph>
  </paragraph>
  <paragraph num="B.">
    <text>For all benefit abuse covered by an MCO’s corrective managed care plan, the plan shall:</text>
    <paragraph num="(1)">
      <text>Use the criteria as described in Regulation .01B of this regulation to determine if enrollees have abused benefits;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Provide for a medical review of the alleged abuse consistent with §C of this regulation;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Provide that an enrollee found to have abused benefits will be enrolled in the program for 24 months;</text>
    </paragraph>
    <paragraph num="(4)">
      <text>Provide that an enrollee who has been enrolled in a 24 month plan and is subsequently found to have abused MCO benefits shall be enrolled in the plan for an additional 36 months;</text>
    </paragraph>
    <paragraph num="(5)">
      <text>Provide for the MCO to select any participating provider in the MCO that meets the requirements of COMAR 10.67.05.05A to serve as the enrollee’s primary care, specialty care, and pharmacy providers for enrollees in corrective managed care, as appropriate to the type of benefit the enrollee has been found to have abused;</text>
    </paragraph>
    <paragraph num="(6)">
      <text>Require an enrollee to obtain prescribed drugs only from a single designated pharmacy provider, which may be any pharmacy or any single branch of a pharmacy chain that participates in the MCO and meets the requirements of COMAR 10.67.05.06B and .07C(2) unless the prescription is:</text>
      <paragraph num="(a)">
        <text>Pursuant to an emergency department visit;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Pursuant to hospital inpatient treatment; or</text>
      </paragraph>
      <paragraph num="(c)">
        <text>A specialty drug as defined in COMAR 10.67.06.04;</text>
      </paragraph>
    </paragraph>
    <paragraph num="(7)">
      <text>Provide enrollees determined to have abused benefits the ability to suggest primary care, specialty care, or pharmacy providers;</text>
    </paragraph>
    <paragraph num="(8)">
      <text>Require the MCO to accept the enrollee’s suggestion referenced in §B(7) of this regulation unless the MCO determines that the recipient’s choice of provider would not serve the enrollee’s best interest in achieving appropriate use of the health care systems and benefits available through the MCO;</text>
    </paragraph>
    <paragraph num="(9)">
      <text>Provide an enrollee determined to have abused benefits 20 days from the date of the notice to present additional documentation to explain the facts that serve as the basis for the MCO’s determination of benefit abuse, consistent with §D of this regulation;</text>
    </paragraph>
    <paragraph num="(10)">
      <text>Provide for the designation of a new primary care, specialty care, or pharmacy provider if the enrollee moves out of the service area of the current primary care or pharmacy provider;</text>
    </paragraph>
    <paragraph num="(11)">
      <text>Provide for prompt reporting to the Department the name of any enrollee enrolled in the MCO’s program, the duration of enrollment, or any change in the duration of enrollment; and</text>
    </paragraph>
    <paragraph num="(12)">
      <text>Be submitted to the Department for review and approval:</text>
      <paragraph num="(a)">
        <text>Within 60 days of the effective date of this regulation; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Before the implementation of any modification.</text>
      </paragraph>
    </paragraph>
  </paragraph>
  <paragraph num="C.">
    <text>The medical review required in §B(2) of this regulation shall:</text>
    <paragraph num="(1)">
      <text>Be performed by a medical reviewer who is a licensed health care professional;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Consider all information that is relevant and available to the MCO, including but not limited to MCO payment records and information secured from any interviews conducted; and</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Where appropriate, consider records obtained from other sources, including:</text>
      <paragraph num="(a)">
        <text>Providers of medical services;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Statistical reports;</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Outside complaints;</text>
      </paragraph>
      <paragraph num="(d)">
        <text>Referrals from other agencies; or</text>
      </paragraph>
      <paragraph num="(e)">
        <text>Any other appropriate sources.</text>
      </paragraph>
    </paragraph>
  </paragraph>
  <paragraph num="D.">
    <text>If an enrollee provides additional information pursuant to §B(9) of this regulation within 20 days:</text>
    <paragraph num="(1)">
      <text>The effective date of the enrollment provided in the notice shall be tolled pending the MCO’s review of the additional information;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>The MCO shall consider whether the additional information changes the MCO’s determination regarding the appropriateness of the enrollee’s enrollment in corrective managed care;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>The MCO shall notify the enrollee of its decision whether the MCO is affirming or reversing its determination to enroll the enrollee in corrective managed care; and</text>
    </paragraph>
    <paragraph num="(4)">
      <text>If the MCO confirms its determination to enroll the enrollee in corrective managed care, the notice shall:</text>
      <paragraph num="(a)">
        <text>Identify the effective date and duration of that enrollment; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Include an explanation of the enrollee’s right to appeal the determination as described in Regulation .05 of this chapter.</text>
      </paragraph>
    </paragraph>
  </paragraph>
  <paragraph num="E.">
    <text>An MCO’s corrective managed care plan may include a process for re-considering, at any interval of time, a decision to enroll an enrollee in the MCO’s corrective managed care plan, if the process entitles the enrollee to appeal the decision pursuant to Regulation .05 of this chapter at the same interval of time.</text>
  </paragraph>
</regulation>